Management of GMP compliance signals
Disclaimer
This presentation paper is provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The paper is not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation paper should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Darika Sowana
- Presented at: Online
- Presentation date: 14 May 2021
- Presentation summary: An overview of GMP compliance signals, how we manage these signals for manufacturers of medicines and biologicals and the kind of information that may be required in the assessment of these signals
-
Webinar presentation: Management of GMP Compliance signals (pdf,899kb)
Related content
-
Information session: Reviewing the exclusion for certain digital mental health tools
This webinar will provide information about the consultation and explain the options for change. -
Information on the Office of Gene Technology Regulator’s Cost Recovery Implementation Statement
This webinar provides an overview of the draft Cost Recovery Implementation Statement (CRIS), including the proposed cost recovery model, implementation approach, and key considerations for stakeholders. -
Accreditation for sunscreen testing laboratories: What sponsors need to know
This webinar is intended for sunscreen sponsors, manufacturers and testing laboratories seeking a clearer understanding of accreditation and how it can support confidence in sunscreen testing and quality assurance.